Quality of Life and Symptom Burden of Patients with MPN during Treatment with Hydroxyurea or Pegylated Interferon-alpha2: Results from a Randomized Controlled Trial

被引：2

作者：

Knudsen, Trine A. ^{[1
]}

Hansen, Dennis Lund ^{[2
]}

Ocias, Lukas Frans ^{[2
]}

Bjerrum, Ole Weis ^{[3
]}

Brabrand, Mette ^{[2
]}

Christensen, Sarah F. ^{[1
]}

Eickhardt-Dalboge, Christina Schjellerup S. ^{[1
]}

Ellervik, Christina ^{[4
,5
,6
,7
,8
]}

El Fassi, Daniel ^{[3
,9
]}

Frederiksen, Mikael ^{[10
]}

Kjaer, Lasse ^{[1
]}

Kristensen, Thomas Kielsgaard ^{[11
]}

Kruse, Torben A. ^{[12
]}

Larsen, Morten Kranker ^{[1
]}

Mourits-Andersen, Torben ^{[13
]}

Overgaard, Ulrik Malthe ^{[3
]}

Severinsen, Marianne Tang ^{[14
]}

Skov, Vibe ^{[1
]}

Sorensen, Anders Lindholm ^{[1
]}

Stentoft, Jesper ^{[15
]}

Starklint, Jorn ^{[16
]}

de Stricker, Karin ^{[11
]}

Thomassen, Mads ^{[12
]}

Larsen, Thomas S. ^{[2
]}

Hasselbalch, Hans Carl ^{[1
,9
]}

机构：

[1] Zealand Univ Hosp, Dept Hematol, Roskilde, Denmark

[2] Odense Univ Hosp, Dept Hematol, Odense, Denmark

[3] Copenhagen Univ Hosp, Rigshosp, Dept Hematol, Copenhagen, Denmark

[4] Reg Zealand, Dept Data & Data Support, Soro, Denmark

[5] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark

[6] Reg Zealand, Dept Prod Res & Innovat, Soro, Denmark

[7] Boston Childrens Hosp, Dept Lab Med, Boston, MA USA

[8] Harvard Med Sch, Dept Pathol, Boston, MA USA

[9] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark

[10] Hosp Southern Jutland, Dept Hematol, Aabenraa, Denmark

[11] Odense Univ Hosp, Dept Pathol, Odense, Denmark

[12] Odense Univ Hosp, Dept Clin Genet, Odense, Denmark

[13] Hosp South West Jutland, Dept Hematol, Esbjerg, Denmark

[14] Aalborg Univ Hosp, Dept Hematol, Aalborg, Denmark

[15] Aarhus Univ Hosp, Dept Hematol, Aarhus, Denmark

[16] Hosp West Jutland, Dept Hematol, Holstebro, Denmark

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-156445

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1794 / 1796

页数：3

共 50 条

[41] Telemedical care and quality of life in patients with schizophrenia and bipolar disorder: results of a randomized controlled trial
Stentzel, Ulrike
van den Berg, Neeltje
Moon, Kilson
Schulze, Lara N.
Schulte, Josephine
Langosch, Jens M.
Hoffmann, Wolfgang
Grabe, Hans J.
BMC PSYCHIATRY, 2021, 21 (01)
[42] Telemedical care and quality of life in patients with schizophrenia and bipolar disorder: results of a randomized controlled trial
Ulrike Stentzel
Neeltje van den Berg
Kilson Moon
Lara N. Schulze
Josephine Schulte
Jens M. Langosch
Wolfgang Hoffmann
Hans J. Grabe
BMC Psychiatry, 21
[43] QUALITY OF LIFE DURING HYPERTENSIVE TREATMENT - RESULTS FROM A RANDOMIZED DOUBLE-BLIND TRIAL OF PINACIDIL AND NIFEDIPINE
FLETCHER, AE
BULPITT, CJ
JOURNAL OF HYPERTENSION, 1989, 7 : S364 - S364
[44] The effect of the smartphone app DiaCert on health related quality of life in patients with type 2 diabetes: results from a randomized controlled trial
Madeleine Hummel
Stephanie Erika Bonn
Ylva Trolle Lagerros
Diabetology & Metabolic Syndrome, 14
[45] The effect of the smartphone app DiaCert on health related quality of life in patients with type 2 diabetes: results from a randomized controlled trial
Hummel, Madeleine
Bonn, Stephanie Erika
Lagerros, Ylva Trolle
DIABETOLOGY & METABOLIC SYNDROME, 2022, 14 (01):
[46] Statins Enhance the Efficacy of Pegylated Interferon-alpha2 in Patients with Ph-Negative Chronic Myeloproliferative Neoplasms. Results from a Danish Single-Institution Cohort Study
Hansen, Isabella Diana
Larsen, Morten Kranker
Skov, Vibe
Kjaer, Lasse
Ellervik, Christina
Sorensen, Anders Lindholm
Knudsen, Trine Alma
Christensen, Sarah Friis
Cordua, Sabrina
Eickhardt-Dalboge, Christina Schjellerup
Wienecke, Troels
Kristiansen, Marie Hvelplund
Hasselbalch, Hans C.
BLOOD, 2024, 144 : 3184 - 3185
[47] Impact on MPN Symptoms and Quality of Life of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia: Interim Analysis Results of Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial
Mesa, Ruben A.
Hoffman, Ronald
Kosiorek, Heidi E.
Prchal, Josef T.
Harrison, Claire N.
McMullin, Mary Frances
Yacoub, Abdulraheem
Rambaldi, Alessandro
Berenzon, Dmitriy
Vannucchi, Alessandro M.
Ewing, Joanne C.
O'Connell, Casey L.
Kiladjian, Jean-Jacques
Mead, Adam
Winton, Elliott F.
Leibowitz, David S.
De Stefano, Valerio
Arcasoy, Murat O.
Kessler, Craig M.
Catchatorian, Rosalind
Rondelli, Damiano
Silver, Richard T.
Ritchie, Ellen K.
Nagler, Arnon
Kremyanskaya, Marina
Schlenk, Richard F.
Weinberg, Rona Singer
Salama, Mohamed E.
Tognoni, Gianni
Prosperini, Giuseppe
Di Lelio, Alessandra
Serone, Eliseo
Marfisi, Lorenzo
Orellana, Alicia
Barbui, Tiziano
Dueck, Amylou C.
Mascarenhas, John O.
BLOOD, 2016, 128 (22)
[48] Economic, clinical, and quality-of-life outcomes associated with olanzapine treatment in mania - Results from a randomized controlled trial
Namjoshi, MA
Rajamannar, G
Jacobs, T
Sanger, TM
Risser, R
Tohen, MF
Breier, A
Keck, PE
JOURNAL OF AFFECTIVE DISORDERS, 2002, 69 (1-3) : 109 - 118
[49] PEGYLATED INTERFERON ALFA-2A VS PEGYLATED INTERFERON ALFA-2B, PLUS RIBAVIRIN, FOR CHRONIC HEPATITIS C GENOTYPE 4 PATIENTS: A RANDOMIZED CONTROLLED TRIAL
Kamal, Sanaa
Ghoraba, Dalia
Nabegh, Leila
Nasser, Imad
Motaoe, Mona
Sayed, Mohamed E.
Gohary, Iman
HEPATOLOGY, 2009, 50 (04) : 1025A - 1026A
[50] Interim analysis of randomized, controlled trial comparing thymosin alpha-1 plus pegylated interferon alpha-2a combination therapy with pegylated interferon alpha-2a monotherapy in HBeAG-positive chronic hepatitis B
Kim, W.
Yoon, J. H.
Lee, Y. J.
Park, S. J.
Kim, B. H.
Lee, J. H.
Yang, J. I.
Myung, S. J.
Km, D. H.
Kim, Y. J.
Lee, H. S.
JOURNAL OF HEPATOLOGY, 2008, 48 : S258 - S258

← 1 2 3 4 5 →